Edwards Lifesciences Corporation Net Cash Provided by (Used in) Investing Activities, Continuing Operations
Edwards Lifesciences Corporation (EW) reported Net Cash Provided by (Used in) Investing Activities, Continuing Operations of -$696.50 million for the 9-month period ending 2017-09-30, per its 10-Q filed 2017-10-27.
Discontinued › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivitiesContinuingOperations · last filed 2017-10-27
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-09-30 was -$209.50M, a 5471.79% decline year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-06-30 was -$638.20M.
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for the quarter ending 2017-03-31 was $151.20M, a 219.66% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for the quarter ending 2016-12-31 was $80.20M, a 193.77% increase year-over-year.
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for fiscal 2016 was -$211.70M.
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for fiscal 2015 was -$316.10M.
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for fiscal 2014 was -$633.00M.
- Edwards Lifesciences Corporation net cash provided by (used in) investing activities, continuing operations for fiscal 2013 was -$412.70M.
| Period end | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 3 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 6 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 9 month as first filed | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month | Net Cash Provided by (Used in) Investing Activities, Continuing Operations 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2017-09-30 | -$209.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | -$847.70M derived: sum of 2 quarters · filed 2017-10-27 | -$696.50M 10-Q · filed 2017-10-27 | -$616.30M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2017-06-30 | -$638.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$487.00M 10-Q · filed 2017-07-28 | -$406.80M derived: sum of 3 quarters · filed 2017-07-28 | -$402.90M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2017-03-31 | $151.20M 10-Q · filed 2017-04-28 | $231.40M derived: sum of 2 quarters · filed 2017-04-28 | $235.30M derived: sum of 3 quarters · filed 2017-10-27 | -$107.80M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2016-12-31 | $80.20M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | $84.10M derived: sum of 2 quarters · filed 2017-10-27 | -$259.00M derived: sum of 3 quarters · filed 2017-10-27 | -$211.70M 10-K · filed 2017-02-17 | ||||
| 2016-09-30 | $3.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27 | -$339.20M derived: sum of 2 quarters · filed 2017-10-27 | -$291.90M 10-Q · filed 2017-10-27 | -$264.60M derived: sum of 4 quarters · filed 2017-10-27 | ||||
| 2016-06-30 | -$343.10M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-28 | -$295.80M 10-Q · filed 2017-07-28 | -$268.50M derived: sum of 3 quarters · filed 2017-07-28 | -$444.10M derived: sum of 4 quarters · filed 2017-07-28 | ||||
| 2016-03-31 | $47.30M 10-Q · filed 2017-04-28 | $74.60M derived: sum of 2 quarters · filed 2017-04-28 | -$101.00M derived: sum of 3 quarters · filed 2017-04-28 | -$88.50M derived: sum of 4 quarters · filed 2017-04-28 | ||||
| 2015-12-31 | $27.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$148.30M derived: sum of 2 quarters · filed 2017-02-17 | -$135.80M derived: sum of 3 quarters · filed 2017-02-17 | -$316.10M 10-K · filed 2017-02-17 | ||||
| 2015-09-30 | -$175.60M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-10-28 | -$163.10M derived: sum of 2 quarters · filed 2016-10-28 | -$343.40M 10-Q · filed 2016-10-28 | -$231.40M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-06-30 | $12.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-07-29 | -$167.80M 10-Q · filed 2016-07-29 | -$55.80M derived: sum of 3 quarters · filed 2017-02-17 | -$210.60M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2015-03-31 | -$180.30M 10-Q · filed 2016-04-29 | -$68.30M derived: sum of 2 quarters · filed 2017-02-17 | -$223.10M derived: sum of 3 quarters · filed 2017-02-17 | -$693.50M derived: sum of 4 quarters · filed 2017-02-17 | ||||
| 2014-12-31 | $112.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-17 | -$42.80M derived: sum of 2 quarters · filed 2017-02-17 | -$513.20M derived: sum of 3 quarters · filed 2017-02-17 | -$633.00M 10-K · filed 2017-02-17 | ||||
| 2014-09-30 | -$154.80M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-10-29 | -$625.20M derived: sum of 2 quarters · filed 2015-10-29 | -$745.00M 10-Q · filed 2015-10-29 | -$991.90M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | -$470.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-07-29 | -$590.20M 10-Q · filed 2015-07-29 | -$837.10M derived: sum of 3 quarters · filed 2016-02-19 | -$943.60M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | -$119.80M 10-Q · filed 2015-04-29 | -$366.70M derived: sum of 2 quarters · filed 2016-02-19 | -$473.20M derived: sum of 3 quarters · filed 2016-02-19 | -$546.20M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | -$246.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$353.40M derived: sum of 2 quarters · filed 2016-02-19 | -$426.40M derived: sum of 3 quarters · filed 2016-02-19 | -$412.70M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | -$106.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-10-31 | -$179.50M derived: sum of 2 quarters · filed 2014-10-31 | -$165.80M 10-Q · filed 2014-10-31 | -$138.40M derived: sum of 4 quarters · filed 2015-02-20 | ||||
| 2013-06-30 | -$73.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$59.30M 10-Q · filed 2014-08-04 | -$44.40M 10-Q · filed 2013-08-06 | -$31.90M derived: sum of 3 quarters · filed 2015-02-20 | -$163.80M derived: sum of 4 quarters · filed 2015-02-20 | |||
| 2013-03-31 | $13.70M 10-Q · filed 2014-05-02 | $27.50M 10-Q · filed 2013-05-06 | $41.10M derived: sum of 2 quarters · filed 2015-02-20 | -$90.80M derived: sum of 3 quarters · filed 2015-02-20 | -$133.50M derived: sum of 4 quarters · filed 2015-02-20 | |||
| 2012-12-31 | $27.40M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-20 | -$104.50M derived: sum of 2 quarters · filed 2015-02-20 | -$147.20M derived: sum of 3 quarters · filed 2015-02-20 | -$78.80M 10-K · filed 2015-02-20 | -$90.50M 10-K · filed 2013-02-28 | |||
| 2012-09-30 | -$131.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | -$174.60M derived: sum of 2 quarters · filed 2013-11-07 | -$106.20M 10-Q · filed 2013-11-07 | -$214.50M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-06-30 | -$42.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | $25.70M 10-Q · filed 2013-08-06 | -$82.60M derived: sum of 3 quarters · filed 2014-02-28 | -$27.30M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2012-03-31 | $68.40M 10-Q · filed 2013-05-06 | -$39.90M derived: sum of 2 quarters · filed 2014-02-28 | $15.40M derived: sum of 3 quarters · filed 2014-02-28 | -$180.00M derived: sum of 4 quarters · filed 2014-02-28 | ||||
| 2011-12-31 | -$108.30M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28 | -$53.00M derived: sum of 2 quarters · filed 2014-02-28 | -$248.40M derived: sum of 3 quarters · filed 2014-02-28 | -$406.50M 10-K · filed 2014-02-28 | -$412.80M 10-K · filed 2012-02-27 | |||
| 2011-09-30 | $55.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$140.10M derived: sum of 2 quarters · filed 2012-11-07 | -$298.20M 10-Q · filed 2012-11-07 | -$81.40M 10-Q · filed 2011-11-08 | -$321.30M derived: sum of 4 quarters · filed 2013-02-28 | |||
| 2011-06-30 | -$195.40M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | -$353.50M 10-Q · filed 2012-08-07 | -$376.60M derived: sum of 3 quarters · filed 2013-02-28 | |||||
| 2011-03-31 | -$158.10M 10-Q · filed 2012-08-07 | -$181.20M derived: sum of 2 quarters · filed 2013-02-28 | ||||||
| 2010-12-31 | -$23.10M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28 | -$61.50M 10-K · filed 2013-02-28 | ||||||
| 2010-09-30 | -$38.40M 10-Q · filed 2011-11-08 | |||||||
| 2009-12-31 | $40.10M 10-K · filed 2012-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| STERIS plc (STE) | Ireland | $20.343B | 25.49 |
| ZIMMER BIOMET HOLDINGS, INC. (ZBH) | United States | $17.103B | 20.66 |
| ALIGN TECHNOLOGY INC (ALGN) | United States | $10.346B | 29.06 |
| MSA Safety Inc (MSA) | United States | $7.023B | 21.47 |
| ESTABLISHMENT LABS HOLDINGS INC. (ESTA) | $1.954B | -65.76 | |
| Cadre Holdings, Inc. (CDRE) | United States | $1.123B | 33.88 |
| Enovis CORP (ENOV) | United States | $1.053B | -1.18 |
| Anteris Technologies Global Corp. (AVR) | United States | $0.746B | |
| Sanara MedTech Inc. (SMTI) | United States | $0.323B | -6.81 |
| Inogen Inc (INGN) | United States | $0.139B | -7.00 |